MBP and myeloid sarcoma: This compound increases MBP expression in rat primary OPCs derived from optic nerves, induce remyelination and decrease significantly clinical symptoms in the experimental autoimmune encephalomyelitis (EAE) model of MS, when administered alone or in combination with approved immunosuppressive treatments for MS, interferon -β and FTY720.